Last updated on April 17, 2014 at 17:30 EDT

The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics

September 27, 2013

DUBLIN, September 27, 2013 /PRNewswire/ –

Research and Markets
( http://www.researchandmarkets.com/research/hg72tl/metabolomics) have announced the
addition of the “The Global Metabolomics Market 2013 Report”
[http://www.researchandmarkets.com/research/hg72tl/metabolomics ] report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769 )

Over the last decade, genomics and proteomics have been used as key tools to discover
potential drug targets and to better understand the complexities of biology. To balance
research in these areas, metabolomics, a new science is evolving for analyzing the basic
metabolic changes taking place in a living organism. Metabolomics is thus an emerging
concept which refers to the systematic study of the distinctive chemical fingerprints
generated in a particular cellular process.

This report covers the market by disease indications along with the applications and
metabolite profiling for biomarker discovery applications. In addition, it also includes
the factors driving and restraining the market and covers the market scenario in the U.S.,
Europe, Asia and the Rest of the World (ROW). This report will provide the company
profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to
supportive factors such as: (i) increased willingness of biotechnology and pharma
companies to adopt metabolomics concept to drive R&D activity within the industry, (ii)
rapid growth of metabolomics data analysis softwares and solutions, and (iii) the
advancement of analytical technologies. Metabolomics
[http://www.researchandmarkets.com/research/hg72tl/metabolomics ] is used in the
identification of new biomarkers, which indicate a change in the physiological state of a
cell or tissue. Biomarker screening is important in the process of new drug discovery, and
is also a key in vitro diagnostics tool. Additionally it is also being used for
environmental toxicology screening. While, there are major concerns of this market such as
the validation challenges, the positive aspects may very well offset the market restraints
to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent
developments and other strategic industry activities. These include:

        - Agilent Technologies
        - Bruker Corporation
        - Metabolomic Technologies
        - Metabolon
        - Chenomx
        - Bio-Rad Laboratories
        - Waters Corporation
        - Human Metabolome Technologies
        - Nextgen Metabolomics
        - Biocrates Life Sciences Ag
        - Stemina Biomarker
        - Phenomenome
        - Metanomics Gmbh
        - Accelrys
        - Eisai Co. Ltd.
        - Shimadzu Corporation
        - Sidmap, Llc
        - Astrazeneca Plc
        - Ab Sciex
        - Metabolomx
        - Research Institute Of Chromatography (Ric)

Key Topics Covered:

        1. Introduction

        2. Executive Summary

        3. Metabolomics -Technology Landscape Analysis

        4. Metabolomics - Market Landscape Analysis

        5. Metabolomics - Technology Investment Potential

        6. Metabolomics - Geographical Analysis

        7. Competitive Landscape Analysis

        8. Patent Analysis

        9. Technology Analysis (Using Multi Criteria Decision Making) & Road Mapping

        10. Analyst Insights & Recommendations

        11. Company Profiles

        For more information visit


        Research and Markets
        Laura Wood, Senior Manager.
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +353-1-481-1716
        Sector: Biotechnology
         [http://www.researchandmarkets.com/categories.asp?cat_id=1&campaign_id=hg72tl ]



SOURCE Research and Markets

Source: PR Newswire